Celyad's IPO

Celyad raised a round of funding on June 21, 2013. Investors include Public.

Celyad, formerly Cardio3 Biosciences, is a biotechnology company focused on the discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases. The com…

Articles about Celyad's IPO: